GENOMICS PROMISES TO ADVANCE HEALTH

Our health depends upon both our genes and our environmental exposure. The current revolution in genomics makes it possible not only to determine our entire DNA sequence but also to begin to understand how our specific genome sequence can inform our health. In addition, our Center has recently demonstrated that it is possible to measure tens of thousands of components in blood to obtain a clear picture of our molecular picture during healthy and disease states.  A combination of such sequence and molecular omics profiling is expected to be powerful in preventing, detecting, understanding, and treating complex diseases such as cancer and inherited diseases that are otherwise difficult to diagnose. Learn more ...

SCGPM FACILITATES TRANSLATION OF GENOMICS INTO PATIENT CENTERED MEDICINE

The Stanford Center for Genomics and Personalized Medicine (SCGPM) seeks to advance genomic technology so that someday both genetic and molecular profiling will become powerful and routine tools for predicting disease risk and monitoring and treating a wide range of pathologies. Towards this mission, the SCGPM serves to centralize and develop collaborative intellectual and technological resources that promote genomic research and analysis, predict drug response, educate physicians, and examine the ethics of personalized medicine. This includes large basic science projects such as ENCODE that decipher the human genome as well as clinical research projects such as the sequencing of cancer genomes and individuals with inherited diseases. Through these efforts, the Center aims to bring genomics to the clinic.

STANFORD POSITIONED TO ADVANCE SCGPM GOALS

SCGPM's promise to translate Genomics into personalized medicine requires a combined focus of intellectual resources. The SCGPM is led by Stanford Professor and renowned genomicist Michael Snyder, Ph.D., and guided by a multidisciplinary executive committee of Stanford biomedical faculty that provides expertise in each of these essential areas.  Stanford University attracts and retains leading researchers in the essential areas of genomic analysis, molecular assays, and computational approaches to medicine. The University is also home to the Pharmacogenomics Knowledgebase PharmGKB, a Master's Program in Genetic Counseling with focus on training students in personal genotype data as well as genetics, and intellectual law resources equipped to help researchers and students examine and address doctor obligation to patients.

SCGPM SEEKS VISIONARY INDIVIDUALS

The promise of SCGPM depends on technologically advanced facilities and intellectual resources. As such, we are looking for visionary individuals who wish to become part of the revolution in personalized medicine by supporting our growth. 

MORE About the SCGPM

The SCGPM was established in 2009 from within the department of Genetics at the Stanford Medical School. The SCGPM now involves more than 60 faculty from 13 departments with diverse research interests spanning basic science to clinical medicine.

A Message from The Director

Mike Snyder Picture

"Genomics is transforming both biological research and medicine. Stanford has long been a leader in this area and continues to develop new approaches to revolutionize the way medicine is practiced, so that disease can be rapidly diagnosed and the right treatment is applied at the right time."

Mike Snyder, PhD
Chair, Stanford Department of Genetics
Stanford W. Ascherman, MD, FACS, Professor of Genetics
Director, SCGPM

Announcements

Sequencing Service Center

The sequencing service center is operational. If you are a Stanford user, click on the "Sequencing" tab above. The service center currently does not accept samples from outside of Stanford.